Preterm Birth and Fetal Fibronectin: Assessing Risk Along the Continuum

Interactive Presentations

Email a Colleague

Preterm Birth and Fetal Fibronectin: Assessing the Risk Along the Continuum

This program was supported by
an educational grant from Cytyc

Full Term - The Fetal Fibronectin Test

Epidemiology of Preterm Birth		Fetal Fibronectin as a Predictor of Preterm Birth
Ashley Roman, MD Assistant Professor of Ob / Gyn NYU School of Medicine New York, NY, USA		Andrei Rebarber, MD Assistant Clinical Professor of Ob / Gyn Mt. Sinai School of Medicine New York, NY, USA
view slide presentation		view slide presentation

		Describe the epidemiology and long term consequences of preterm birth in the United States
		Identify symptomatic and asymptomatic women at risk of spontaneous preterm birth
		Understand the role of fetal fibronectin testing as an important tool for assessing risk
		Describe strategies to benefit women at risk of spontaneous preterm birth
Roman & Rebarber "Practice Insights"

The opinions, beliefs, and viewpoints expressed by the contributors to this webcast do not necessarily reflect the opinions, beliefs, and viewpoints of Cytyc, the sponsor of this webcast, or obgyn.net. Neither Cytyc, obgyn.net, nor webcast contributors make any guarantee about or accept any legal liability or responsibility for the currency, accuracy, or quality of information presented in this webcast, or for any claims resulting from information contained in this webcast or in any other information electronically linked to this webcast.